Trials / Conditions / Transplant Glomerulopathy
Transplant Glomerulopathy
4 registered clinical trials studyying Transplant Glomerulopathy.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Active Not Recruiting | Clazakizumab in Highly-HLA Sensitized Patients Awaiting Renal Transplant NCT03380962 | Stanley Jordan, MD | Phase 1 / Phase 2 |
| Completed | Clazakizumab for Chronic and Active Antibody Mediated Rejection Post-Kidney Transplant NCT03380377 | Stanley Jordan, MD | Phase 1 / Phase 2 |
| Terminated | Treatment of Chronic Antibody-mediated Rejection in Kidney Transplant With Acthar NCT02546492 | University of Maryland, Baltimore | Phase 4 |
| Terminated | Acthar as Rescue Therapy for Transplant Glomerulopathy in Kidney Transplant Recipients NCT02057523 | University of Illinois at Chicago | Phase 4 |